Page 317 - Clinical Immunology_ Principles and Practice ( PDFDrive )

298 ParT TwO Host Defense Mechanisms and Inflammation

39. Fukuyama Y, King JD, Kataoka K, et al. Secretory-IgA antibodies play an Haemophilus influenzae type b studied in an infant rat model. J Infect Dis
important role in the immunity to Streptococcus pneumoniae. J Immunol 1996;174:1337–40.
2010;185:1755–62. 48. Singh K, Chang C, Gershwin ME. IgA deficiency and autoimmunity.
40. Kataoka K, McGhee JR, Kobayashi R, et al. Nasal Flt3 ligand cDNA elicits Autoimmun Rev 2014;13:163–77.
+
+
CD11c CD8 dendritic cells for enhanced mucosal immunity. J Immunol 49. Williams IR, Owen RL. M cells: Specialized antigen sampling cells in the
2004;172:3612–19. follicle-associated epithelium. In: Mestecky J, Strober W, Russell MW,
41. Sekine S, Kataoka K, Fukuyama Y, et al. A novel adenovirus expressing et al, editors. Mucosal Immunology. 4th ed. Cambridge, MA: Elsevier;
Flt3 ligand enhances mucosal immunity by inducing mature 2015. p. 211–30.
nasopharyngeal-associated lymphoreticular tissue dendritic cell 50. Burns JW, Siadat-Pajouh M, Krishnaney AA, et al. Protective effect of
migration. J Immunol 2008;180:8126–34. rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing
42. Haq TA, Mason HS, Clements JD, et al. Oral immunization with a activity. Science 1996;272:104–7.
recombinant bacterial antigen produced in transgenic plants. Science 51. Cuff CF, Cebra CK, Rubin DH, et al. Developmental relationship between
1995;268:714–16. cytotoxic α/β T cell receptor-positive intraepithelial lymphocytes and
43. Tacket CO, Mason HS, Losonsky G, et al. Immunogenicity in humans of Peyer’s patch lymphocytes. Eur J Immunol 1993;23:1333–9.
a recombinant bacterial antigen delivered in a transgenic potato. Nat Med 52. Allan W, Tabi Z, Cleary A, et al. Cellular events in the lymph node and
1998;4:607–9. lung of mice with influenza. Consequences of depleting CD4+ T cells. J
44. Nochi T, Takagi H, Yuki Y, et al. Rice-based mucosal vaccine as a global Immunol 1990;144:3980–6.
strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci 53. Carding SR, Allan W, Kyes S, et al. Late dominance of the inflammatory
+
USA 2007;104:10986–91. process in murine influenza by γ/δ T cells. J Exp Med 1990;172:1225–31.
45. Nochi T, Yuki Y, Katakai Y, et al. A rice-based oral cholera vaccine induces 54. Miller CJ, McChesney MB, Lu X, et al. Rhesus macaques previously
macaque-specific systemic neutralizing antibodies but does not influence infected with simian/human immunodeficiency virus are protected from
pre-existing intestinal immunity. J Immunol 2009;183:6538–44. vaginal challenge with pathogenic SIVmac239. J Virol 1997;71:1911–21.
46. Tokuhara D, Yuki Y, Nochi T, et al. Secretory IgA-mediated protection 55. Goronzy JJ, Weyand CM. Understanding immunosenescence to improve
against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic responses to vaccines. Nat Immunol 2013;14:428–36.
Escherichia coli by rice-based vaccine. Proc Natl Acad Sci USA 56. Fujihashi K, Kiyono H. Mucosal immunosenescence: new developments
2010;107:8794–9. and vaccines to control infectious diseases. Trends Immunol
47. Kauppi-Korkeila M, van Alphen L, Madore D, et al. Mechanism of 2009;30:334–43.
antibody-mediated reduction of nasopharyngeal colonization by